I am a
Home I AM A Search Login

Papers of the Week


Papers: 25 Dec 2021 - 31 Dec 2021


Human Studies

PAIN TYPE:
Migraine/Headache


2021 Dec 29


Eur J Neurol

Clinic and genetic predictors in response to erenumab.

Authors

Zecca C, Cargnin S, Schankin C, Giannantoni N M, Viana M, Maraffi I, Riccitelli G C, Sihabdeen S, Terrazzino S, Gobbi C
Eur J Neurol. 2021 Dec 29.
PMID: 34965002.

Abstract

Erenumab (ERE) is the first anti-calcitonin gene related peptide (CGRP) receptor monoclonal antibody approved for migraine prevention. A proportion of patients does not adequately respond to ERE.